J. Piesvaux

发表

Virus-Based Expression Systems Facilitate Rapid Target In Vivo Functionality Validation and High-Throughput Screening

Zina Itkin, Mary Jo Wildey, Sergey E. Ilyin, 2003, Journal of biomolecular screening.

Nuclear pseudomagnetism in holmium ethylsulphate: New mechanisms of nuclear relaxation

A. Abragam, J. Piesvaux, P. Mériel, 1976 .

Identification of an allosteric binding site for RORγt inhibition

C. Ottmann, Sujata Sharma, H. van Eenennaam, 2015, Nature Communications.

Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor

Irena Ivanovska, C. Chiu, I. Kariv, 2017, The Journal of Pharmacology and Experimental Therapeutics.

Pseudo Magnetic Moments of H 1 and V 51 Measured by a New Method

A. Abragam, J. Piesvaux, P. Mériel, 1973 .

Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool Compounds.

X. Fradera, Haiyan Xu, M. Bittinger, 2021, ACS medicinal chemistry letters.

STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors

J. Cumming, Sarah Javaid, A. Tse, 2021, Molecular Cancer Therapeutics.

Systematic pseudomagnetic measurements of the spin-dependent scattering length of slow neutrons with atomic nuclei

A. Abragam, J. Piesvaux, P. Mériel, 1974 .

Spin-dependent scattering lengths of slow neutrons with nuclei by pseudomagnetic measurements

A. Abragam, H. Glattli, J. Piesvaux, 1975 .

Discovery of MK-1454: A Potent Cyclic Dinucleotide Stimulator of Interferon Genes Agonist for the Treatment of Cancer.

Andrew M Haidle, Matthew L. Maddess, J. Cumming, 2022, Journal of medicinal chemistry.

Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.

M. Vandermeeren, M. Mercken, C. Ho, 2010, Bioorganic & medicinal chemistry letters.

Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of Anemia.

C. Chiu, J. Metzger, Liming Yang, 2018, ACS medicinal chemistry letters.

An orally available non-nucleotide STING agonist with antitumor activity

Andrew M Haidle, J. Cumming, I. Kariv, 2020, Science.

Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 Inhibitors

I. Kariv, X. Chai, X. Fradera, 2020, SLAS discovery : advancing life sciences R & D.

Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors.

Michael J. Ardolino, Karin M. Otte, M. Kennedy, 2021, Journal of medicinal chemistry.

Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease.

Theodore A. Martinot, Michael J. Ardolino, Matthew L. Maddess, 2022, Journal of medicinal chemistry.

Identification of Potent Reverse Indazole Inhibitors for HPK1.

X. Fradera, Haiyan Xu, M. Bittinger, 2021, ACS medicinal chemistry letters.

Measurement of the Spin-Dependent Part of the Scattering Amplitude of Slow Neutrons onF19Using a Polarized Beam and a Polarized Target

A. Abragam, J. Piesvaux, P. Mériel, 1972 .